Keros Therapeutics, Inc. · NASDAQ:KROS

Pontifax Management 4 GP (2015) Ltd. reported a 0% stake in Keros Therapeutics, Inc. (Schedule 13D/A)

Event Oct 15, 2025 · Filed Oct 16, 2025

Pontifax Management 4 GP (2015) Ltd. reported a 0% stake in Keros Therapeutics, Inc., 0 shares, with active intent on Oct 15, 2025. Filed Oct 16, 2025 (Schedule 13D/A).

Stake
0%
Shares
0
Intent
Active
What changed
Stake changed
Filed together
6 holders

The filing in full

HolderStakeShares
Pontifax Management 4 GP (2015) Ltd.0%0
Pontifax (Israel) IV, L.P.0%0
Pontifax (Cayman) IV, L.P.0%0
Pontifax (China) IV, L.P.0%0
Pontifax Late Stage Fund L.P.0%0
Pontifax Late Stage GP Ltd.0%0

Source

View original at SEC

Related